Diversified Trust Co Acquires New Position in Sotera Health Company $SHC

Diversified Trust Co bought a new stake in Sotera Health Company (NASDAQ:SHC – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 33,998 shares of the company’s stock, valued at approximately $629,000.

A number of other institutional investors also recently added to or reduced their stakes in SHC. Russell Investments Group Ltd. grew its position in Sotera Health by 55.5% in the third quarter. Russell Investments Group Ltd. now owns 146,001 shares of the company’s stock valued at $2,700,000 after acquiring an additional 52,120 shares during the period. Fifth Third Bancorp lifted its stake in shares of Sotera Health by 2.3% during the third quarter. Fifth Third Bancorp now owns 55,641 shares of the company’s stock valued at $1,029,000 after acquiring an additional 1,263 shares during the period. New Mexico Educational Retirement Board grew its position in shares of Sotera Health by 1.5% during the 3rd quarter. New Mexico Educational Retirement Board now owns 55,600 shares of the company’s stock worth $1,028,000 after buying an additional 800 shares during the period. Ritholtz Wealth Management acquired a new stake in shares of Sotera Health during the third quarter worth $189,000. Finally, Lido Advisors LLC boosted its stake in Sotera Health by 29.0% during the 3rd quarter. Lido Advisors LLC now owns 18,646 shares of the company’s stock worth $345,000 after acquiring an additional 4,196 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently weighed in on SHC. JPMorgan Chase & Co. cut their price objective on Sotera Health from $17.00 to $15.00 and set an “underweight” rating on the stock in a report on Wednesday, November 4th. Barclays dropped their price objective on shares of Sotera Health from $22.00 to $20.00 and set an “overweight” rating on the stock in a report on Wednesday, November 4th. Citigroup increased their target price on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 7th. Finally, Piper Sandler restated an “overweight” rating and set a $25.00 target price on shares of Sotera Health in a report on Tuesday, September 8th. Seven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and an average price target of $21.14.

Get Our Latest Stock Report on SHC

Sotera Health Stock Down 1.2%

NASDAQ:SHC opened at $16.05 on Wednesday. Sotera Health Company has a twelve month low of $13.09 and a twelve month high of $19.85. The firm has a market capitalization of $4.58 billion, a price-to-earnings ratio of 18.47 and a beta of 1.94. The company has a quick ratio of 2.91, a current ratio of 3.13 and a debt-to-equity ratio of 3.04. The stock’s 50 day moving average price is $17.86 and its two-hundred day moving average price is $16.89.

Sotera Health (NASDAQ:SHC – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.02. The business had revenue of $324.89 million during the quarter, compared to analysts’ expectations of $319.86 million. Sotera Health had a net margin of 14.11% and a return on equity of 38.46%. The firm’s revenue was up 4.4% on a year-over-year basis. During the same period last year, the business earned $0.26 earnings per share. Equities research analysts expect that Sotera Health Company will post 0.89 earnings per share for the current fiscal year.

About Sotera Health

(Free Report)

Sotera Health Company is a global provider of sterilization, laboratory testing and advisory services for the medical device, pharmaceutical and food industries. Its services help customers assess product safety, meet regulatory requirements and prepare products for use. Through Sterigenics, the company provides contract sterilization using technologies including ethylene oxide, gamma irradiation and electron beam processing. Nelson Labs offers microbiological and analytical testing, as well as consulting, for medical devices and pharmaceutical products.

Featured Stories

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC – Free Report).

Institutional Ownership by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.